Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
Clinical trial NCT06257394 · RECRUITING
Trial details
- NCT number
- NCT06257394
- Sponsor
- Hyoung Jin Kang
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-20
- Primary completion
- 2034-12-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.